ADVFN - Advanced Financial Network.
HOME» NYSE » B » BSX Stock Price » BSX Stock News

Boston Scientific Share News

 Boston Scientific Corp. Stock Price
BSX Stock Price
 Boston Scientific Corp. Stock Chart
BSX Stock Chart
 Boston Scientific Corp. Stock News
BSX Stock News
 Boston Scientific Corp. Company Information
BSX Company Information
 Boston Scientific Corp. Stock Trades
BSX Stock Trades

Boston Scientific CEO Kucheman's 2011 Total Pay Rose 47% To $4.7 Million

By Anjali Athavaley Of DOW JONES NEWSWIRES NEW YORK -(Dow Jones)- Boston Scientific Corp. (BSX) Chief Executive William H. Kucheman's total pay jumped 47% to $4.7 million last year after he was named interim head of the Natick, Mass., medical-device maker. President Michael F. Mahoney, Kucheman's eventual replacement, received total compensation valued at $11.7 million last year, according to a filing Thursday with the Securities & Exchange Commission. Last fall, the company named Mahoney, previously the world-wide chairman of rival Johnson & Johnson's (JNJ) medical device and diagnostics group, as its new CEO in a complicated arrangement. Under the plan, Mahoney joined Boston Scientific as president in October and is expected to become CEO Nov. 1 this year. Kucheman, formerly president of the company's cardiology, rhythm and vascular group, is serving as interim CEO until then. Boston Scientific said in a regulatory filing last fall Mahoney would get an annual salary of $900,000 plus a sign-on bonus of $1.5 million and an additional bonus of $750,000 to be paid within 30 days following his promotion to president and CEO. He also would receive $9.5 million in deferred stock. As interim CEO, Kucheman would receive an annual salary of $900,000, the company has said. Shares were unchanged after-hours after closing up 3.5% at $5.93 Thursday. -By Anjali Athavaley, Dow Jones Newswires; 212-416-4912;

Stock News for Boston Scientific (BSX)
10/09/201514:44:42Boston Arrives Late To The Mitral Valve Party
10/08/201506:30:00Boston Scientific Announces Additional Investment And Right To...
10/07/201517:00:00Boston Scientific Launches Online Competition For New Digital...
10/07/201516:30:00Boston Scientific Announces Scheduled Presentations At TCT 2015
10/05/201516:11:28Statement of Changes in Beneficial Ownership (4)
10/05/201516:06:37Current Report Filing (8-k)
10/05/201506:30:00Boston Scientific Receives FDA Approval For SYNERGY™ Bioabsorbable P...
10/02/201516:24:35Statement of Changes in Beneficial Ownership (4)
10/02/201516:24:35Statement of Changes in Beneficial Ownership (4)
10/02/201516:24:35Statement of Changes in Beneficial Ownership (4)
10/02/201516:23:21Statement of Changes in Beneficial Ownership (4)
10/01/201508:30:00Boston Scientific To Webcast Third Quarter 2015 Earnings Call...
09/29/201509:00:00Boston Scientific Launches The Captivator™ EMR Device To Treat D...
09/28/201507:00:00New Survey Reveals True Impact of Severe Asthma on People's Lives
09/28/201506:00:00Eluvia™ Drug-eluting Vascular Stent System Demonstrates 12-month P...
09/22/201508:45:00Technical Data on Healthcare Stocks - Infinity Pharmaceuticals...
09/18/201508:30:00Medical Appliances and Equipment Stocks Technical Report -- Boston...
09/10/201509:00:00Boston Scientific Announces CE Mark for the Vercise™ Primary C...
09/02/201508:30:00Boston Scientific To Participate In 2015 Morgan Stanley Global...
08/26/201508:30:00Boston Scientific To Participate In The 2015 Wells Fargo Healthcare...

Boston Scientific and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations